Vibe Growth Past Earnings Performance
Past criteria checks 0/6
Vibe Growth's earnings have been declining at an average annual rate of -20.8%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 4.3% per year.
Key information
-20.8%
Earnings growth rate
-14.1%
EPS growth rate
Healthcare Industry Growth | 15.7% |
Revenue growth rate | -4.3% |
Return on equity | -12,682.0% |
Net Margin | -68.7% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Vibe Growth makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 12 | -8 | 8 | 0 |
30 Jun 24 | 12 | -10 | 8 | 0 |
31 Mar 24 | 13 | -11 | 8 | 0 |
31 Dec 23 | 14 | -11 | 9 | 0 |
30 Sep 23 | 15 | -11 | 9 | 0 |
30 Jun 23 | 17 | -10 | 9 | 0 |
31 Mar 23 | 19 | -10 | 9 | 0 |
31 Dec 22 | 21 | -9 | 10 | 0 |
30 Sep 22 | 23 | -6 | 9 | 0 |
30 Jun 22 | 25 | -6 | 8 | 0 |
31 Mar 22 | 27 | -5 | 8 | 0 |
31 Dec 21 | 29 | -4 | 8 | 0 |
30 Sep 21 | 30 | -1 | 7 | 0 |
30 Jun 21 | 30 | 0 | 7 | 0 |
31 Mar 21 | 28 | 1 | 6 | 0 |
31 Dec 20 | 24 | 1 | 6 | 0 |
30 Sep 20 | 21 | -3 | 5 | 0 |
30 Jun 20 | 18 | -5 | 5 | 0 |
31 Mar 20 | 16 | -7 | 5 | 0 |
31 Dec 19 | 13 | -9 | 5 | 0 |
30 Sep 19 | 9 | -9 | 8 | 0 |
31 Dec 18 | 0 | -6 | 5 | 0 |
Quality Earnings: 3ST is currently unprofitable.
Growing Profit Margin: 3ST is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3ST is unprofitable, and losses have increased over the past 5 years at a rate of 20.8% per year.
Accelerating Growth: Unable to compare 3ST's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 3ST is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).
Return on Equity
High ROE: 3ST has a negative Return on Equity (-12682.03%), as it is currently unprofitable.